There is a growing number of drugs that need to be in controlled temperatures. A lot of newly approved drugs are
biological, therefore, must be handled in cold chain, meaning between 2 and 8 degrees Celsius. Other
examples of temperature sensitive drugs are insulin and vaccines.
When these drugs are exposed for a prolonged period outside the cold chain area,
it loses its efficacy. If you inject children with such a vaccine, they
will not build up the expected immunity and they still run a health risk.
Pharmaceutical companies and regulatory authorities take this cold chain very serious. Pharma companies need to
comply to the GDP (General Distribution Practices). But unfortunately, the GDP regulation is limited between the
production and the arrival at a pharmacy or in a hospital.
Quite some drugs are self-injectable, and it means that patients get these drugs in the pharmacy and take it home:
that is the last mile where patients are responsible for the right temperature handling.
A temperature logger based on the NTAG SmartSensor will provide insights in the temperature handling and patients can
check whether their drug is OK to use.
Thanks to the flexibility of the NTAG SmartSensor, partners and sellers can easily create derivatives with
our examples in the SDK: vaccine indicators returning that the drug is still good to use or by implementing a
dedicated APP connected to the cloud, pharma companies can create proof of the patient outcome. Patients taking care
of their drugs see their therapy working.